These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31343713)

  • 1. Opioid e-prescribing trends at discharge in a large pediatric health system.
    Horvat CM; Martin B; Wu L; Fabio A; Empey PE; Hagos F; Bigelow S; Kantawala S; Au AK; Kochanek PM; Clark RSB
    J Opioid Manag; 2019; 15(2):119-127. PubMed ID: 31343713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in Urologic Discharge Opioid Prescribing after Mandatory Query of Statewide Prescription Drug Monitoring Program.
    Myrga JM; Macleod LC; Bandari J; Jacobs BL; Davies BJ
    Urology; 2020 May; 139():84-89. PubMed ID: 32061826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
    Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
    JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
    Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
    BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.
    Stucke RS; Kelly JL; Mathis KA; Hill MV; Barth RJ
    JAMA Surg; 2018 Dec; 153(12):1105-1110. PubMed ID: 30140927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
    Manders L; Abd-Elsayed A
    Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
    Martello J; Cassidy B; Mitchell A
    J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of prescription drug monitoring program mandate on postoperative opioid prescriptions in children.
    Theodorou CM; Jackson JE; Rajasekar G; Nuño M; Yamashiro KJ; Farmer DL; Hirose S; Brown EG
    Pediatr Surg Int; 2021 May; 37(5):659-665. PubMed ID: 33433663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
    Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
    MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.
    Deyo RA; Hallvik SE; Hildebran C; Marino M; Springer R; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM; Carson J; Wakeland W; McCarty D
    J Pain; 2018 Feb; 19(2):166-177. PubMed ID: 29054493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
    Brown WC; Whitted K
    J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Opioid Prescribing Habits Based on Analysis of a State Prescription Drug Monitoring Program.
    Alexander JC; Silge J; Jones S; Joshi GP
    Pain Physician; 2019 Sep; 22(5):E425-E433. PubMed ID: 31561654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refilling Opioid Prescriptions After Pediatric Orthopaedic Surgery: An Analysis of Incidence and Risk Factors.
    Meza BC; Swarup I; Woodard T; Cazzulino A; Talwar D; Shah AS
    J Pediatr Orthop; 2021 Mar; 41(3):e291-e295. PubMed ID: 33534368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of automatic physician review of prescription drug monitoring program data on opioid prescribing in a Maryland statewide hospital system.
    Stryckman B; Schoenbaum A; Klein J; Chasm R; Onukwugha E; Dezman ZD
    J Opioid Manag; 2022; 18(6):547-556. PubMed ID: 36523206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of New York State Electronic Prescribing Mandate on Opioid Prescribing Patterns.
    Danovich D; Greenstein J; Chacko J; Hahn B; Ardolic B; Ilyaguyev B; Berwald N
    J Emerg Med; 2019 Aug; 57(2):156-161. PubMed ID: 31256931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
    Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
    Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.